Day: June 18, 2024

CHEERS Telepathy Production Mystical Realm of Mountains and Seas Season 1 Proved a Great Success

BEIJING, June 18, 2024 (GLOBE NEWSWIRE) — Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, announced today that as of June 15, the total number of online view counts of topics including # Mystical Realm of Mountains and Seas and # CHEERS Telepathy on social media platforms, including TikTok, Kuaishou, Red, Tencent Video, iXigua and Weibo has exceeded 11 million, creating heated discussions among audiences since the first release on June 5, 2024. Inspired by magnificent and imaginative ancient Chinese masterpiece, The Classic of Mountains and Seas. The first season has five episodes: The Tree of the Evil Spirit, The Beginning of the World in Chaos, Taoyuan Estate, The Birth of the Evil God, and The...

Continue reading

Parsons and the Niagara International Transportation Technology Coalition Celebrate Bi-National Project Milestone

CHANTILLY, Va., June 18, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) and the Niagara International Transportation Technology Coalition (NITTEC) are pleased to announce the successful launch of AllRoads, NITTEC’s multi-agency, technology-enabled, integrated regional mobility management system. This smart mobility solution services the Buffalo-Niagara region in Western New York State and Southern Ontario. Since 2022, Parsons has worked closely with NITTEC to design, develop, and implement the first bi-national deployment of AllRoads. The solution is built on Parsons’ artificial intelligence (AI) based Smart Mobility Solution, iNET®, which seamlessly integrates with the client’s existing advanced traffic management system, transit operations, and traffic signal network. The integrated mobility management system furthers...

Continue reading

China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China

SHENZHEN, CHINA, June 18, 2024 (GLOBE NEWSWIRE) — Innovative drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets (Lumeblue®) is an oral diagnostic drug, approved by China’s NMPA for enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy. The results of the Phase III clinical trial in China show that the Product can significantly improve the detection rate of non-polypoid colorectal lesions (the primary endpoint of the study), leading to an improved detection rate of dangerous lesions such as non-polypoid adenomas (the secondary endpoint). The Product can be taken during the bowel preparation step, ensuring that colorectal staining is completed by the time colonoscopy is conducted. This not only enhances the detection rate of colorectal lesions but also...

Continue reading

Interim report Q2 2023/24 – Half year

Roblon’s revenue and earnings for the first half of 2023/24 were in line with expectations Selected financial highlights The Group’s order intake amounted to DKKm 185.9 in H1 2023/24 (DKKm 175.6), and at 30 April 2024, the Group’s order book stood at DKKm 106.0 (DKKm 118.6). Revenue of DKKm 155.0 (DKKm 171.7). Gross margin of 52.3% (49.5%). Operating profit before depreciation, amortisation and impairment and special items (EBITDA) of DKKm 4.4 (DKKm 6.3). Operating loss before special items (EBIT) of DKKm 8.7 (a loss of DKKm 7.5). Financial items amounted to a net expense of DKKm 2.1 (net expense of DKKm -3.0). Loss before tax of DKKm 10.8 (loss of DKKm -10.5). Net cash inflow from operations of DKKm 35.0 (DKKm 24.5). Full-year guidance for 2023/24 Management maintains the previously announced guidance of revenue of around DKKm 370,...

Continue reading

Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act

Company announcement, Helsinki, 18 June 2024 at 11:30 AM (EEST) Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) has received a notification pursuant to chapter 9, section 5 of the Securities Market Act from Ossi Haapaniemi on 17 June 2024. The notification is based on the amendment to the Securities Market Act effective April 19, 2024, requiring shareholders to notify the target company and the Financial Supervisory Authority of their ownership and voting shares no later than two months after the enactment of this law if the shareholder’s stake in the target company is at least five percent at the time the law takes effect and such share has not been previously disclosed. Total position of person subject to the notification...

Continue reading

Canadian Businesses Lean on New Installment Loans For Debt Repayment as Delinquencies Rise

– Interest Rate Cut May Bring Some Relief as Business Owners Grapple with Loan Repayments – Equifax® Canada’s Market Pulse Q1 2024 Business Credit Trends TORONTO, June 18, 2024 (GLOBE NEWSWIRE) — According to the latest data from Equifax® Canada’s Market Pulse Q1 2024 Business Credit Trends Report, new installment loan originations surged by 74 per cent year-over-year in the second half of 2023. Businesses that raced to meet the Canada Emergency Business Account (CEBA) forgiveness deadline of January 18th, 2024 could potentially be driving this higher-than-seasonal demand. “While it may feel like CEBA is moving into the rear-view mirror, it’s truly a matter of businesses turning to new installment loans to secure their financial stability,” said Jeff Brown, Head of Commercial Solutions for Equifax Canada....

Continue reading

Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023

Tokyo, Japan and Cambridge, UK, 18 June 2024 – Nxera Pharma (“Nxera” or “the Company”; TSE 4565), today announces the publication of its Annual Report and its Environment, Social & Governance (ESG) Report for the year ended 31 December 2023. The Annual Report can be found by clicking here. The ESG Report can be found by clicking here. –END– About Nxera Pharma Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally.   In addition to several products being commercialized in Japan, we are advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing...

Continue reading

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Small Cell Lung Cancer

SHANGHAI, June 18, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for toripalimab (product code: JS001) in combination with etoposide plus platinum for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC). Lung cancer is currently the most prevalent malignant tumor with the highest mortality rate in China. Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer, accounting for approximately 15%-20% of all lung cancer cases with characteristics including rapid progression,...

Continue reading

Meriaura Group Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act

Meriaura Group Plc Company announcement, Major holdings                            18.6.2024 klo 9.00 (CEST) Disclosure under Chapter 9 Section 10 of the Securities Market Act Meriaura Group Plc has received on June 17, 2024, a flagging notification from Jussi-Pekka Mälkiä in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act, indicating that the ownership of Meriaura Invest Oy, under his control, exceeds 50% of the share capital and voting rights of Meriaura Group Plc as of April 19, 2024. In April, an amendment to the Securities Markets Act came into effect, extending the flagging obligation to companies listed on Nasdaq First North as well. The flagging notification was made in accordance with and within the two-month transition period included in the legislative amendment. Meriaura Group Plc has one share series,...

Continue reading

Signify delivers plan to reduce greenhouse gas emissions by 90% across its entire value chain and reach net-zero by 2040

Press Release June 18, 2024 Signify delivers plan to reduce greenhouse gas emissions by 90% across its entire value chain and reach net-zero by 2040 Signify Climate Transition Plan targets entire value chain to eliminate 90% full-scope GHG emissions and reach net-zero by 2040. Completing the switch to energy-efficient LED lighting would reduce total global GHG emissions by 1%, equivalent to half the emissions caused by aviation1, more than enough electricity to charge every electric car currently on the road, or power over 100 million heat pumps2. Signify will work closely with customers, partners, and public decision-makers to accelerate the sustainable energy transition. Eindhoven, NL – Signify (Euronext: LIGHT), the world leader in lighting, has released its plan to reduce greenhouse gas (GHG) emissions by 90% across its entire value...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.